Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

  • Who should read the report

    R&D and formulation, regulatory, business decision-makers at beauty-pharma intersection, brand owners and product managers, pharma and consumer-health sectors.

  • Key insights you'll gain

    • Claims-First Development Framework

    Discover how determining claim wording and evidence requirements at formulation stage transforms regulatory compliance into competitive advantage, enabling defensible "clinically proven" positioning while controlling testing costs and development timelines across global markets.

    • Multi-Regime Evidence Architecture

    Learn how to build a single, governed evidence file satisfying efficacy, environmental, ethical, and manufacturing standards simultaneously—with jurisdiction-specific versioning for EU, UK, US MoCRA, China NMPA, and Korea MFDS requirements that eliminates costly duplicate testing and late-stage compliance failures.

Introduction

Setting the stage for transformation in Americas pharmaceutical manufacturing

Innovation, Resilience, and Strategy – the CPHI Americas Roundtable

Exclusive perspectives from industry thought leaders on building resilient supply chains and embracing collaborative ecosystems

Beyond the Stage: Conference Insights

Key takeaways from five dedicated content tracks covering R&D, sustainability, the LATAM pharma landscape, Women's Networking Event, and more

Start-Up Stories: Zymvol Biomodeling

Breakthrough innovations from emerging companies reshaping the pharmaceutical value chain

Sustainability in a Fragmented Global Economy

Practical strategies for environmental responsibility amid supply chain complexity and regulatory diversity

The Road to Miami 2027

Why Miami's emergence as a pharmaceutical hub matters for your business—from world-class logistics infrastructure to business-friendly environment and growing industry presence

Contributors

Meet the experts and organizations shaping the conversation

References

Supporting data and sources

Download the report

Personal Details
Company Details

New zone

Cosmeceuticals

As demand grows for evidence-led skincare, clinically substantiated ingredients, advanced formulations and dermocosmetic products are moving closer to the pharma ecosystem.

The companies behind them will be familiar from our API and CDMO zones, but the new Cosmeceuticals zone at CPHI Frankfurt 2027 will bring this growing audience together for the first time.

  • A $75–90B market growing 7–10% CAGR through 2030

  • Rising demand for clinically proven, evidence-led skincare is accelerating category growth

  • Dermocosmetic decision-makers are driving premium pharmacy and clinic expansion

Cosmeceuticals zone

Who you could meet

The pharma side of beauty; buyers who evaluate cosmeceuticals as a pharma-grade opportunity:

Brand owners 
building dermocosmetic portfolios.

R&D & formulation teams 
sourcing clinically substantiated actives and delivery systems.

Business development & sourcing leaders
finding contract-manufacturing and innovation partners.

Regulatory & compliance professionals
substantiating claims.

Pharma, consumer-health & wellness decision-makers
exploring cosmeceutical opportunities.



CPHI in numbers

Europe's largest pharmaceutical event

35
years
CONNECTING THE GLOBAL PHARMA SUPPLY CHAIN
62000
+
attendees
160
+
Countries represented
250
+
Expert speakers

Exhibit

Secure your founding exhibitor position in the Cosmeceutical zone at CPHI Frankfurt 2027, helping to define the future of evidence-led cosmetics within pharma.

Attend

Experience CPHI Frankfurt 2027 first-hand before joining the founding cohort of the Cosmeceutical zone.